Company news
BCAL Diagnostics Limited news in 2024
BCAL Diagnostics Limited's news releases, calls and decks from 2024, newest first.
NATA Accreditation Clarification
December 12, 2024
BCAL Diagnostics Receives NATA Accreditation
December 11, 2024
Appendix 4E and Annual Report to Shareholders
August 30, 2024
BCAL Commences US Operations
August 28, 2024
BCAL Receives Firm Commitments to Raise $10.5 Million
June 3, 2024
Reinstatement to Quotation
June 3, 2024
Suspension from Quotation
May 30, 2024
Response to ASX Price Query
May 30, 2024
Trading Halt
May 29, 2024
Pause in Trading
May 29, 2024
Appointment of Strategic CEO to Lead Commercial Launch
March 5, 2024
Decks in 2024
- Shareholder Meeting (November 2024)
Shareholder meeting · 21 slides · Nov 22, 2024
- Spark+ Australian Equities Day (September 2024)
Conference · 24 slides · September 2024
- 18th Bioshares Biotech Summit 2024
Conference · 21 slides · Jul 11, 2024
- JMM & Ethica Capital - Innovation & Investment Insights (May 2024)
Conference · 16 slides · May 2, 2024
- Investor Presentation (March 2024)
Investor deck · 26 slides · Mar 6, 2024